| CASE REPORT |
|
| Year : 2014 | Volume
: 7
| Issue : 2 | Page : 78-80 |
|
|
Long-term results of intravitreal ranibizumab for osteoma-related choroidal neovascularization in a child
Aditi Gupta1, Lingam Gopal2, Parveen Sen1, Dhanashree Ratra1, Chetan Rao1
1 Department of Vitreoretinal Services, Shri Bhagwan Mahavir, 18, College Road, Sankara Nethralaya, Chennai, Tamil Nadu, India
2 Department of Ophthalmology, National University Hospital, 5 Lower Kent Ridge Road, Singapore
Correspondence Address:
Aditi Gupta
Vitreo-Retina Fellow, Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, College Road, Chennai - 600 006, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-620X.137162
|
|
|
Though choroidal osteoma is a rare benign tumor, associated choroidal neovascularization (CNV) can be a cause of severe visual loss. A nine-year-old boy presented with one-month history of decreased vision in left eye. Upon a complete ophthalmologic examination, including fundus fluorescein angiography and optical coherence tomography, he was diagnosed with choroidal osteoma-related subfoveal CNV in the left eye. The CNV was associated with subretinal hemorrhage, subretinal fluid, and cystoid macular edema. Owing to the young age and subfoveal localization of the CNV, intravitreal ranibizumab injection was performed on this patient after a detailed discussion with the parents of its safety profile. No local or systemic complications were noted. No recurrence of CNV lesion was noted during 30 months of follow-up, and the vision was maintained. This report shows the favorable outcome of intravitreal injection of ranibizumab in choroidal osteoma-related CNV in a child. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
